Edgard Andrade
Neurology with Special Qualifications in Child Neurology · Gainesville, FLNPI 1013023399
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,602 and has fallen 61.3% since, to $620 in 2025.
Across 105 payments — averaging $45.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$771
- SK Life Science, Inc.$684
- Greenwich Biosciences, Inc.$675
- UCB, Inc.$545
- Neurelis, Inc.$365
- Sunovion Pharmaceuticals Inc.$351
- plus $1K from 11 others
What the payments were for
- Food & beverage$4,69799%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 9 | $771 |
| SK Life Science, Inc. | 9 | $684 |
| Greenwich Biosciences, Inc. | 16 | $675 |
| UCB, Inc. | 12 | $545 |
| Neurelis, Inc. | 6 | $365 |
| Sunovion Pharmaceuticals Inc. | 8 | $351 |
| Eisai Inc. | 13 | $283 |
| Teva Pharmaceuticals USA, Inc. | 3 | $245 |
| AstraZeneca | 2 | $215 |
| Medtronic | 3 | $136 |
| Supernus Pharmaceuticals, Inc. | 7 | $122 |
| Biomarin Pharmaceutical Inc. | 3 | $96 |
| Tris Pharma Inc | 5 | $94 |
| Aquestive Therapeutics, Inc. | 4 | $64 |
| Genentech USA, Inc. | 1 | $41 |
| Livanova USA, Inc. | 2 | $36 |
| Zogenix Inc. | 2 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,757 in reported general payments places this provider in the 55th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 13 | $756 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Gainesville
- Peter KangGainesville$23K
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ronald DavisWinter Park$154K
- Ian MillerMiami$104K
- Michael HammerSaint Petersburg$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.